Cargando…
The Treatment of Peri-Implant Diseases: A New Approach Using HYBENX(®) as a Decontaminant for Implant Surface and Oral Tissues
Background: Peri-implantitis is a pathological condition characterized by an inflammatory process involving soft and hard tissues surrounding dental implants. The management of peri-implant disease has several protocols, among which is the chemical method HYBENX(®). The aim of this study is to demon...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147150/ https://www.ncbi.nlm.nih.gov/pubmed/33946370 http://dx.doi.org/10.3390/antibiotics10050512 |
_version_ | 1783697562936541184 |
---|---|
author | Lopez, Michele Antonio Passarelli, Pier Carmine Godino, Emmanuele Lombardo, Nicolò Altamura, Francesca Romana Speranza, Alessandro Lopez, Andrea Papi, Piero Pompa, Giorgio D’Addona, Antonio |
author_facet | Lopez, Michele Antonio Passarelli, Pier Carmine Godino, Emmanuele Lombardo, Nicolò Altamura, Francesca Romana Speranza, Alessandro Lopez, Andrea Papi, Piero Pompa, Giorgio D’Addona, Antonio |
author_sort | Lopez, Michele Antonio |
collection | PubMed |
description | Background: Peri-implantitis is a pathological condition characterized by an inflammatory process involving soft and hard tissues surrounding dental implants. The management of peri-implant disease has several protocols, among which is the chemical method HYBENX(®). The aim of this study is to demonstrate the efficacy of HYBENX(®) in the treatment of peri-implantitis and to compare HYBENX(®) with other chemical agents used in the surgical treatment of peri-implantitis. Methods: The present study included a population of ten subjects with severe peri-implantitis. The procedure used in the study involves the application of HYBENX(®) after open-flap debridement. Each patient has been followed for 12 months after a single application of the decontaminant agent. Clinical and radiographical parameters were recorded at baseline, 3 months, and 12 months after treatment completion. Results: At baseline, a mean pocket probing depth (PPD) of 7.3 ± 0.5 mm and a mean clinical attachment level (CAL) of 8.8 ± 0.8 mm was recorded. An average residual PPD of 4.2 ± 0.5 mm and a mean CAL of 5.2 ± 0.8 mm were observed after 1 year. Additionally, the average of bone gain was about 3.4 mm, with a mean marginal bone level (MBL) change from 5.8 mm (baseline) to 2.4 mm (12 months). In total, 90% of the treated implants reached the success rate after the 1-year follow-up. Only in one case out of ten treated implants was resolution of the disease not achieved. Conclusion: Clinical improvements highlight that the procedure of open-flap debridement (OFD) + HYBENX(®) may be considered an effective technique in the treatment of peri-implantitis. From the results obtained, it can be concluded that the use of HYBENX(®) in the surgical treatment of peri-implantitis is promising. Overall, this protocol demands further studies to better understand the role and potential benefits of HYBENX(®) in the treatment of peri-implantitis. |
format | Online Article Text |
id | pubmed-8147150 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81471502021-05-26 The Treatment of Peri-Implant Diseases: A New Approach Using HYBENX(®) as a Decontaminant for Implant Surface and Oral Tissues Lopez, Michele Antonio Passarelli, Pier Carmine Godino, Emmanuele Lombardo, Nicolò Altamura, Francesca Romana Speranza, Alessandro Lopez, Andrea Papi, Piero Pompa, Giorgio D’Addona, Antonio Antibiotics (Basel) Article Background: Peri-implantitis is a pathological condition characterized by an inflammatory process involving soft and hard tissues surrounding dental implants. The management of peri-implant disease has several protocols, among which is the chemical method HYBENX(®). The aim of this study is to demonstrate the efficacy of HYBENX(®) in the treatment of peri-implantitis and to compare HYBENX(®) with other chemical agents used in the surgical treatment of peri-implantitis. Methods: The present study included a population of ten subjects with severe peri-implantitis. The procedure used in the study involves the application of HYBENX(®) after open-flap debridement. Each patient has been followed for 12 months after a single application of the decontaminant agent. Clinical and radiographical parameters were recorded at baseline, 3 months, and 12 months after treatment completion. Results: At baseline, a mean pocket probing depth (PPD) of 7.3 ± 0.5 mm and a mean clinical attachment level (CAL) of 8.8 ± 0.8 mm was recorded. An average residual PPD of 4.2 ± 0.5 mm and a mean CAL of 5.2 ± 0.8 mm were observed after 1 year. Additionally, the average of bone gain was about 3.4 mm, with a mean marginal bone level (MBL) change from 5.8 mm (baseline) to 2.4 mm (12 months). In total, 90% of the treated implants reached the success rate after the 1-year follow-up. Only in one case out of ten treated implants was resolution of the disease not achieved. Conclusion: Clinical improvements highlight that the procedure of open-flap debridement (OFD) + HYBENX(®) may be considered an effective technique in the treatment of peri-implantitis. From the results obtained, it can be concluded that the use of HYBENX(®) in the surgical treatment of peri-implantitis is promising. Overall, this protocol demands further studies to better understand the role and potential benefits of HYBENX(®) in the treatment of peri-implantitis. MDPI 2021-04-30 /pmc/articles/PMC8147150/ /pubmed/33946370 http://dx.doi.org/10.3390/antibiotics10050512 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lopez, Michele Antonio Passarelli, Pier Carmine Godino, Emmanuele Lombardo, Nicolò Altamura, Francesca Romana Speranza, Alessandro Lopez, Andrea Papi, Piero Pompa, Giorgio D’Addona, Antonio The Treatment of Peri-Implant Diseases: A New Approach Using HYBENX(®) as a Decontaminant for Implant Surface and Oral Tissues |
title | The Treatment of Peri-Implant Diseases: A New Approach Using HYBENX(®) as a Decontaminant for Implant Surface and Oral Tissues |
title_full | The Treatment of Peri-Implant Diseases: A New Approach Using HYBENX(®) as a Decontaminant for Implant Surface and Oral Tissues |
title_fullStr | The Treatment of Peri-Implant Diseases: A New Approach Using HYBENX(®) as a Decontaminant for Implant Surface and Oral Tissues |
title_full_unstemmed | The Treatment of Peri-Implant Diseases: A New Approach Using HYBENX(®) as a Decontaminant for Implant Surface and Oral Tissues |
title_short | The Treatment of Peri-Implant Diseases: A New Approach Using HYBENX(®) as a Decontaminant for Implant Surface and Oral Tissues |
title_sort | treatment of peri-implant diseases: a new approach using hybenx(®) as a decontaminant for implant surface and oral tissues |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147150/ https://www.ncbi.nlm.nih.gov/pubmed/33946370 http://dx.doi.org/10.3390/antibiotics10050512 |
work_keys_str_mv | AT lopezmicheleantonio thetreatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues AT passarellipiercarmine thetreatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues AT godinoemmanuele thetreatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues AT lombardonicolo thetreatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues AT altamurafrancescaromana thetreatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues AT speranzaalessandro thetreatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues AT lopezandrea thetreatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues AT papipiero thetreatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues AT pompagiorgio thetreatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues AT daddonaantonio thetreatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues AT lopezmicheleantonio treatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues AT passarellipiercarmine treatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues AT godinoemmanuele treatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues AT lombardonicolo treatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues AT altamurafrancescaromana treatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues AT speranzaalessandro treatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues AT lopezandrea treatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues AT papipiero treatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues AT pompagiorgio treatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues AT daddonaantonio treatmentofperiimplantdiseasesanewapproachusinghybenxasadecontaminantforimplantsurfaceandoraltissues |